Drug

Toludesvenlafaxine clinical trials

Also written LY03005.

studies test it: 15
open now: 5
in phase 3: 1
first study started: 2014

Keep track of what changes. Save the toludesvenlafaxine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

15 studies that test it; most in 2024 (3)

Studies that test toludesvenlafaxine, by start year
Year	Studies
2014	2
2015	1
2016	1
2017	1
2018	2
2019	1
2023	2
2024	3
2025	1
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 7
Phase 3: 1
Phase 4: 3
No phase: 4

What it is tested for

Each study’s main condition, where its own words name it.

Depressive Disorder, Major: 9
Medically Unexplained Symptoms: 1
Depression: 1
Fibromyalgia: 1
Anhedonia: 1

Who runs them

Industry 9 · Other 6

Luye Pharma Group Ltd. (9) · Shanghai Mental Health Center (2) · Beijing Tiantan Hospital (2) · First Affiliated Hospital of Zhejiang University (1) · Jiangsu Province Nanjing Brain Hospital (1)

Often tested with

Tested in the same studies.

Desvenlafaxine (2) · Pregabalin (1)

Studies

Open first, then newest update. How each study uses toludesvenlafaxine is read from its arms, and is right about nine times in ten.

Testing it · 15

Codes

What other systems call toludesvenlafaxine · ClinicalTrials.gg INT015982

UNII (FDA) A7CGH459FNTOLUDESVENLAFAXINEOne source FDA
NCI Thesaurus C171708ToludesvenlafaxineOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	A7CGH459FN	TOLUDESVENLAFAXINE	One source FDA
NCI Thesaurus	C171708	Toludesvenlafaxine	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.